Dr. Aparna Goel, MD
Claim this profileStanford Medicine
Affiliated Hospitals
Stanford Medicine
Stanford Clinic
Clinical Trials Aparna Goel, MD is currently running
INT-787
for Alcoholic Hepatitis
This trial tests a new drug called INT-787 for people with severe liver damage from heavy drinking. It aims to see if the drug is safe and effective, and how the body processes it. The goal is to find out if INT-787 can help improve liver health in these patients. Previous studies have shown that similar treatments can protect against liver injury.
Recruiting
0 awards
Phase 2
Oral Hymecromone
for Primary Sclerosing Cholangitis
Primary objective: To evaluate the efficacy of hymecromone plus standard of care compared with standard of care alone in the treatment of adolescents and adults with primary sclerosing cholangitis (PSC). Secondary objectives: To evaluate the change in Alkaline Phosphatase (ALP) from baseline to 6 months post-treatment following treatment with hymecromone plus standard of care compared with standard of care. To evaluate changes in biomarkers of PSC disease during hymecromone treatment, namely: (a) fibrotic effect (FibroScan); (b) inflammatory biomarkers (serum Hyaluronan (HA)); and, (c) T-cell count.
Recruiting
1 award
Phase 2
2 criteria
More about Aparna Goel, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Aparna Goel, MD has experience with
- Hymecromone
- Placebo
- Zetomipzomib
- INT-787
- Empagliflozin
Breakdown of trials Aparna Goel, MD has run
Primary Sclerosing Cholangitis
Autoimmune Hepatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aparna Goel, MD specialize in?
Aparna Goel, MD focuses on Hepatitis and Liver Cirrhosis. In particular, much of their work with Hepatitis has involved treating patients, or patients who are undergoing treatment.
Is Aparna Goel, MD currently recruiting for clinical trials?
Yes, Aparna Goel, MD is currently recruiting for 2 clinical trials in Redwood City California. If you're interested in participating, you should apply.
Are there any treatments that Aparna Goel, MD has studied deeply?
Yes, Aparna Goel, MD has studied treatments such as Hymecromone, Placebo, Zetomipzomib.
What is the best way to schedule an appointment with Aparna Goel, MD?
Apply for one of the trials that Aparna Goel, MD is conducting.
What is the office address of Aparna Goel, MD?
The office of Aparna Goel, MD is located at: Stanford Medicine, Redwood City, California 94063 United States. This is the address for their practice at the Stanford Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.